KHNYN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.502000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.325400E-01
Normal-vs-Stage2
4.727000E-01
Normal-vs-Stage3
1.459000E-01
Normal-vs-Stage4
7.171200E-01
Stage1-vs-Stage2
6.765800E-01
Stage1-vs-Stage3
2.228600E-01
Stage1-vs-Stage4
7.011800E-01
Stage2-vs-Stage3
6.582500E-02
Stage2-vs-Stage4
7.772400E-01
Stage3-vs-Stage4
3.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.509400E-01
Normal-vs-AfricanAmerican
2.726400E-01
Normal-vs-Asian
1.914950E-01
Caucasian-vs-AfricanAmerican
8.860000E-01
Caucasian-vs-Asian
7.556000E-01
AfricanAmerican-vs-Asian
9.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.543000E-01
Normal-vs-Female
4.489000E-01
Male-vs-Female
9.076800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.891600E-01
Normal-vs-Age(41-60Yrs)
5.592400E-01
Normal-vs-Age(61-80Yrs)
4.044200E-01
Normal-vs-Age(81-100Yrs)
4.401000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.232800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.913800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.778800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.776500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.749200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.291200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.176600E-01
Normal-vs-Daily Drinker
1.367630E-01
Normal-vs-Weekly Drinker
3.588600E-01
Normal-vs-Occasional Drinker
5.256800E-01
Normal-vs-Social Drinker
5.170800E-01
Non Drinker-vs-Daily Drinker
6.028600E-01
Non Drinker-vs-Weekly Drinker
4.525200E-01
Non Drinker-vs-Occasional Drinker
2.686800E-01
Non Drinker-vs-Social Drinker
2.988000E-01
Daily Drinker-vs-Weekly Drinker
2.889600E-01
Daily Drinker-vs-Occasional Drinker
6.064000E-01
Daily Drinker-vs-Social Drinker
6.491200E-01
Weekly Drinker-vs-Occasional Drinker
1.176050E-01
Weekly Drinker-vs-Social Drinker
1.137990E-01
Occasional Drinker-vs-Social Drinker
9.481200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.554100E-02
Normal-vs-Grade 2
1.969510E-02
Normal-vs-Grade 3
1.144110E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.148800E-01
Grade 1-vs-Grade 3
1.069410E-01
Grade 1-vs-Grade 4
7.554100E-02
Grade 2-vs-Grade 3
2.575500E-02
Grade 2-vs-Grade 4
1.969510E-02
Grade 3-vs-Grade 4
1.144110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.815200E-01
Normal-vs-NonDiabetic
4.418200E-01
Diabetic-vs-NonDiabetic
2.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.569600E-01
Normal-vs-NoPancreatitis
4.211600E-01
Pancreatitis-vs-NoPancreatitis
7.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.261400E-01
Normal-vs-N1
4.596600E-01
N0-vs-N1
5.089200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.750400E-01
Normal-vs-TP53-NonMutant
4.397200E-01
TP53-Mutant-vs-TP53-NonMutant
8.318400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
